The trademark application IMMUBROVIR was filed by Superbiotics, SPRL, a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on May 24, 2023, and it was registered by office on August 31, 2023 without any oppositions.
The application was filed in French (English was selected as the second language).